Skip to main content
. 2022 Jan 14;12(1):111. doi: 10.3390/brainsci12010111

Table 2.

Simple linear regression analyses with APPLIQue as the dependent variable, n = 74.

Independent Variables Unstandardized Standardized p-Value
Coefficient β (95% CI) Coefficient β
Patient data
Age (year) −0.198 (−0.400 to 0.003) −0.225 0.053
PD duration −0.141 (−0.336 to 0.054) −0.167 0.155
Patient gender (ref = male) −3.935 (−6.744 to −1.125) −0.313 0.007
Partner 4.017 (0.603 to 7.431) 0.266 0.022
Dwelling place (home vs. nursing home) −1.252 (−4.195 to 1.691) −0.099 0.399
Hoehn and Yahr stage 1.200 (−2.106 to 4.507) 0.085 0.472
ADL independency (S&E) −0.022 (−0.126 to 0.082) −0.05 0.674
Home health care (yes) 0.950 (−2.427 to 4.328) 0.066 0.577
Cognition, MMSE −0.088 (−0.324 to 0.148) −0.09 0.458
Cognitive impairment (dichotomized 0–23 vs. 24–30) −4.271 (−7.135 to −1.407) −0.337 0.004
Depressive symptoms (GDS-30) −0.065 (−0.295 to 0.166) −0.069 0.578
Depression (dichotomized 0–9 vs. 10–30) −0.561 (−3.549 to 2.428) −0.046 0.709
Motor function (UPDRS III total score) 0.039 (−0.053 to 0.132) 0.099 0.399
Non-motor symptomatology (NMSS total score) 0.036 (0.008 to 0.065) 0.292 0.012
Hallucinations (NMSS item 13) 0.206 (−0.209 to 0.621) 0.116 0.325
Hallucinations (dichotomized 0 vs. ≥ 1) 1.368 (−1.531 to 4.267) 0.11 0.350
Delusions (NMSS item 14) 0.089 (−0.546 to 0.723) 0.033 0.781
Delusions (dichotomized 0 vs. ≥ 1) 1.167 (−2.364 to 4.698) 0.077 0.512

CI, confidence interval; PD, Parkinson’s disease; APPLIQue, the Alzheimer’s Patient Partners Life Impact Questionnaire (score range 0–25, higher = worse); q1–q3, first and third quartiles; ref, reference category; HY, Hoehn and Yahr staging scale (score range I-V, higher = worse); ADL, activities of daily living; S&E, Schwab and England ADL scale (score range 0–100, higher = better); MMSE, Mini-mental state examination (score range 0–30, higher = better); NMSS, Non-Motor Symptoms Scale (0–360, higher = worse); GDS-30, Geriatric Depression Scale (score range 0–30, higher = worse); UPDRS III, Unified PD Rating Scale, part III = motor examination (score range 0–108, higher = worse). Bold p-values are statistically significant at p < 0.05.